Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company spanning cannabis, craft beverages, hemp-based foods and wellness products. News about TLRY commonly covers product launches, brand refreshes and retail distribution across beverage and food subsidiaries such as BrewDog, 10 Barrel Brewing, SweetWater Brewing Company, Widmer Brothers Brewing and Manitoba Harvest.
Company updates also address Tilray Medical, international medical cannabis markets, Canadian adult-use and medical cannabis activity, quarterly operating results, acquisitions and capital actions. Recurring coverage links Tilray’s cannabis platform with its beverage and wellness portfolio across North America, Europe and other international markets.
Tilray (Nasdaq: TLRY) launched PORTAL on April 8, 2026, a high‑intensity cannabis brand targeting experienced, high‑tolerance consumers across Canada.
PORTAL debuts infused pre‑rolls and liquid‑diamond vapes with THCA diamond coatings and products ranging from >40% THC pre‑rolls to 95–99% THC cartridges, available at select provincial retailers.
Breckenridge Distillery (NASDAQ: TLRY) relaunched Breckenridge Honey Whiskey on April 7, 2026, an expression infused with rare Goldswarm Raw Honey from Nigeria.
It is bottled at 36% ABV (72 proof), available in 750ml, 1L, 1.75L and 50ml formats, with Colorado retailers now and national retail availability planned for mid‑April.
Tilray Brands (Nasdaq: TLRY) reported record Q3 fiscal 2026 results for quarter ended Feb 28, 2026: net revenue $206.7M (+11% YoY) and gross profit $55.0M (+6% YoY). Cannabis net revenue rose to $64.8M (+19%), led by international cannabis +73%. Distribution net revenue reached a record $83.0M. Adjusted EBITDA was $10.7M (+19%). Cash, restricted cash and marketable securities totaled $264.8M and net cash improved to $3.5M versus prior-year net debt. BrewDog acquisition (~£40M) closed after quarter end and is not reflected in results. Management reaffirmed fiscal 2026 adjusted EBITDA guidance of $62M–$72M while noting geopolitical risks could affect outlook.
Tilray Beverages (TLRY) brand Shock Top launched High Voltage, its first high-ABV double wheat beer, at 9.6% ABV in 19.2 oz cans priced from $2.99. The beer features orange peel and orange puree, bright citrus notes, and a smooth wheat finish. A Southern California debut precedes nationwide expansion to large-format and convenience stores beginning in May.
According to the company, High-ABV singles led craft spending in 2025, and High Voltage is positioned to capture that trend with a bold citrus-forward profile and on-premise/off-premise rollout.
Tilray Brands (Nasdaq: TLRY) announced a licensing partnership with The Magnum Ice Cream Company to launch Popsicle Hard ready-to-drink malt beverages in the U.S. The line features 5% ABV Hard Cherry, Hard Orange and Hard Grape in a variety pack rolling out March 2026 at major retailers.
The red-white-and-blue Popsicle Hard Firecracker flavor will follow in May 2026 in 12-packs of 12-ounce slim cans. Products will be sold at Walmart, Kroger, Albertson's, Safeway, Food Lion, Ingles and Buc-ees. More info at www.popsiclehard.com.
Tilray Brands (Nasdaq: TLRY) will release third fiscal quarter results for the period ended February 28, 2026 before markets open on Wednesday, April 1, 2026. The company will host a live conference call and audio webcast at 8:30 AM ET the same day.
Investors can access the webcast via the Events & Presentations section of Tilray's Investor Relations website for results discussion and Q&A.
Tilray Medical (NASDAQ: TLRY) announced its largest medical cannabis portfolio expansion in Australia on March 19, 2026, adding new products across multiple formats to increase patient access within Australia’s regulated medical system.
The expansion will introduce Redecan extracts, flower, vapes and pastilles, and Good Supply flower offerings over the coming months.
Breckenridge Distillery (NASDAQ: TLRY) announced a Colorado partnership with Cheba Hut on March 18, 2026, rolling out its Bourbon Whiskey at 18 Cheba Hut locations.
Mountain Shot, a chocolate-mint shootable whiskey, will be available at select Boulder, Dillon, and one Denver restaurant. Drink specials, including shot-and-a-beer combos, will vary by location. Guests must be 21+.
Tilray Brands (NASDAQ: TLRY) entered an asset purchase agreement to acquire key BrewDog U.S. assets, including the Columbus, Ohio brewery, three Ohio pubs, one Columbus hotel, the Las Vegas flagship brewpub, a franchised Denver location, and a licensed Columbus airport site.
The transaction is expected to close in Q4 FY2026, pending customary regulatory approvals, and follows Tilray's prior BrewDog operating asset deals and global ownership of the BrewDog brand and intellectual property.
Tilray (Nasdaq: TLRY) announced a strategic German alliance effective April 1, 2026, joining Tilray Medical, CC Pharma, 14U Pharma and the "gesund leben" cooperation operated by Alliance Healthcare Deutschland.
The alliance leverages Alliance Healthcare's 27 logistics centers, daily supply to 10,000+ pharmacies, and the "gesund leben" network of ~3,600 member pharmacies to broaden pharmacy access, offer Rx, parallel-import discounts and Tilray's medical cannabis portfolio nationwide.